[1]
Ruggeri, M. and Rolli, F.R. 2019. Cost per response/remission in biologics available in Italy for the treatment of TNF-α inhibitors-naïve patients with ulcerative colitis. Global and Regional Health Technology Assessment. 6, 1 (Aug. 2019). DOI:https://doi.org/10.33393/grhta.2019.456.